Piñeyro Pablo Enrique, Lozada Maria Inez, Alarcón Laura Valeria, Sanguinetti Ramon, Cappuccio Javier Alejandro, Pérez Estefanía Marisol, Vannucci Fabio, Armocida Alberto, Madson Darin Michael, Perfumo Carlos Juan, Quiroga Maria Alejandra
Veterinary Diagnostic Laboratory, 1655 Veterinary Medicine, Iowa State University, 1850 Christensen Drive, Ames, IA, 50011, USA.
Laboratorio de Patología Especial Veterinaria FCV-UNLP, Calle 60 y 118 S/N (1900), La Plata, Buenos Aires, Argentina.
BMC Vet Res. 2018 Sep 24;14(1):292. doi: 10.1186/s12917-018-1615-9.
In 2014, a notification of porcine transmissible gastroenteritis virus (TGEV) was made by the National Services of Animal Health of Argentina (SENASA) to the World Organization of Animal Health (OIE). The notification was based on a serological diagnosis in a small farm with a morbidity rate of 2.3% without enteric clinical signs. In order to determine if TGEV was circulating before the official report, a retrospective study on cases of neonatal diarrhea was performed. The selection criteria was a sudden increase in mortality in 1- to 21-day-old piglets with watery diarrhea that did not respond to antibiotics. Based on these criteria, three clinical cases were identified during 2010-2015.
All animals that were evaluated presented histological lesions consistent with enteric viral infection. The feces and ultrathin sections of intestine that were evaluated by electron microscopy confirmed the presence of round particles of approximately 80 nm in size and characterized by finely granular electrodense nucleoids consistent with complete particles of coronavirus. The presence of the TGEV antigen was confirmed by monoclonal specific immunohistochemistry, and final confirmation of a metabolically-active virus was performed by in situ hybridization to detect a TGE mRNA encoding spike protein. All sections evaluated in this case were negative for PEDV and rotavirus A.
This is the first case series describing neonatal mortality with etiological confirmation of TGEV in Argentina. The clinical diagnosis of TGEV infections in endemic regions is challenging due to the epidemiological distribution and coinfection with other enteric pathogens that mask the clinical presentation.
2014年,阿根廷国家动物卫生服务局(SENASA)向世界动物卫生组织(OIE)通报了猪传染性胃肠炎病毒(TGEV)。该通报基于一个小型农场的血清学诊断,发病率为2.3%,无肠道临床症状。为了确定TGEV在官方报告之前是否已经传播,对新生儿腹泻病例进行了回顾性研究。选择标准是1至21日龄仔猪死亡率突然增加,伴有水样腹泻且对抗生素无反应。根据这些标准,在2010 - 2015年期间确定了3例临床病例。
所有接受评估的动物均呈现与肠道病毒感染一致的组织学病变。通过电子显微镜评估的粪便和肠道超薄切片证实存在大小约为80纳米的圆形颗粒,其特征是具有精细颗粒状电子致密核仁,与冠状病毒的完整颗粒一致。通过单克隆特异性免疫组织化学证实了TGEV抗原的存在,并通过原位杂交检测编码刺突蛋白的TGE mRNA对代谢活跃病毒进行了最终确认。该病例中评估的所有切片对猪流行性腹泻病毒(PEDV)和轮状病毒A均为阴性。
这是阿根廷首例描述经病因学证实的TGEV导致新生儿死亡的病例系列。由于流行病学分布以及与其他肠道病原体的共同感染掩盖了临床表现,TGEV感染在流行地区的临床诊断具有挑战性。